New drug pricing rules on Canada Day will end years of damaging uncertainty for industry and patients

Over the past five years, Canadians have had less access to innovative medicines that treat diseases such as cancer and rare disorders than Americans and Europeans.

The changes add several lower-priced countries to the basket of those to which Canada’s prices must be compared to determine the maximum permissible price, while removing the U.S. and Switzerland from the mix to lower the price ceiling. Unsplash photograph by Laurynas Mereckas

Opinion

BY JASON FIELD

June 30, 2022

When there is uncertainty, businesses of any kind have to assume and prepare for the worst. This is especially true when investing billions of dollars in very risky multi-year projects to develop and launch new medicines around the world. And if one country creates a uniquely unfavourable and uncert...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy